表紙
市場調查報告書

全球單回使用生物製程系統市場:2019年∼2024年的預測

Single-use Bioprocessing System Market by Product, Application, End-users, and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 300227
出版日期 內容資訊 英文 190 Pages
訂單完成後即時交付
價格
Back to Top
全球單回使用生物製程系統市場:2019年∼2024年的預測 Single-use Bioprocessing System Market by Product, Application, End-users, and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年10月29日內容資訊: 英文 190 Pages
簡介

全球單回使用生物製程系統市場在2019年∼2024年間,預測將以超過11%的年複合成長率成長。為了達成低成本高生產率的技術,抑制污染風險在最小限度的技術,治療各種疾病的生物醫藥品的需求等,為該市場的成長要素。

本報告提供全球單回使用生物製程系統市場的相關調查,市場趨勢,成長要素及課題,產品、用途、終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 序言1
  • 序言2
  • 美金的匯率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模、預測
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 產業內的競爭
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔
  • 比較
  • 袋子、攪拌機
  • 生物反應器、發酵槽
  • 過濾設備、取樣調查系統
  • 生物流程容器
  • 其他
  • 市場機會

第7章 市場區隔:各用途

  • 市場區隔
  • 比較
  • mAb生產
  • 疫苗的生產
  • 植物細胞的栽培
  • PSCT
  • 其他
  • 市場機會

第8章 客戶形勢

第9章 市場區隔:各終端用戶

  • 市場區隔
  • 比較
  • 製藥公司
  • CRO、CMO
  • 生物科技企業
  • 學術、研究機關
  • 市場機會

第10章 各地區的預測

  • 市場區隔
  • 地區
  • 北美
  • 歐洲
  • 亞洲
  • 其他
  • 主要國家
  • 市場機會

第11章 決策架構

第12章 成長要素及課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

第14章 業者情勢

  • 概要
  • 形勢的混亂
  • 競爭模式

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場上地位
  • 3M Co.
  • Avantor Inc.
  • Compagnie de Saint-Gobain SA
  • Danaher Corp.
  • Eppendorf AG
  • General Electric Co.
  • Merck KGaA
  • Sartorius AG
  • Solaris Biotechnology Srl
  • Thermo Fisher Scientific Inc.

第16章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第17章 關於TECHNAVIO

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR40062

About this market

Technavio's single-use bioprocessing system market analysis considers sales from bags and mixers, bioreactors and fermenters, filtration devices and sampling systems, bioprocess containers, and other products. Our report also provides a detailed analysis of the market Asia, Europe, North America, and ROW. In 2019, the bags and mixers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as low contamination and the reduction in downtimes by eliminating the need for cleaning validation, will play a significant role in the bags and mixers product segment to maintain its market position. Also, our global single-use bioprocessing system market report looks at factors such as the substantial use of single-use technology to achieve lower costs and higher productivity, the increasing use of single-use technologies to minimize the risk of contamination, and the high demand for biopharmaceuticals to treat various diseases. However, issues related to extractables and leachables in polymeric systems, scale up issues in commercial applications of single-use technologies, and validation issues while selecting suppliers and integrators may hamper the growth of the single-use bioprocessing system industry over the forecast period.

Overview

Substantial use of single-use technology to achieve lower costs and higher productivity

The use of SUB systems in commercial-scale production eliminates the need to perform clean validation and SIP, reducing the cost and time spent on sterilization, maintenance, and cleaning of metal systems. The use of such disposable technologies also reduces the initial costs associated with quality control. Thus, leading to the intense competition among pharmaceutical and biotechnology companies which in turn, increases the need to develop rapid and low-cost capacities without compromising on the quality and safety of products. This leads to the expansion of the global single-use bioprocessing system market at a CAGR of over 11% during the forecast period.

Product advances and automation

The advanced SUB systems have optimized the production process and eliminated the need for additional manpower. This has led the vendors to start integrating their products with industrial automation platforms such as sensors, probes, processing software, and customizing automation capabilities to suit end-user needs. These developments is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global single-use bioprocessing system market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global single-use bioprocessing system market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading single-use bioprocessing system manufacturers, that include 3M Co., Avantor Inc., Compagnie de Saint-Gobain SA, Danaher Corp., Eppendorf AG, General Electric Co., Merck KGaA, Sartorius AG, Solaris Biotechnology Srl., and Thermo Fisher Scientific Inc.

Also, the single-use bioprocessing system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Bags and mixers - Market size and forecast 2019-2024
  • Bioreactors and fermenters - Market size and forecast 2019-2024
  • Filtration devices and sampling systems - Market size and forecast 2019-2024
  • Bioprocess containers - Market size and forecast 2019-2024
  • Other products - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • mAb production - Market size and forecast 2019-2024
  • Vaccine production - Market size and forecast 2019-2024
  • Plant cell cultivation - Market size and forecast 2019-2024
  • PSCTs - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical companies - Market size and forecast 2019-2024
  • CROs and CMOs - Market size and forecast 2019-2024
  • Biotechnology companies - Market size and forecast 2019-2024
  • Academic and research institutions - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Rising focus of market vendors on strategic partnerships
  • Growing product advancements and automation
  • Increasing adoption of modular facilities among biomanufacturers

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 3M Co.
  • Avantor Inc.
  • Compagnie de Saint-Gobain SA
  • Danaher Corp.
  • Eppendorf AG
  • General Electric Co.
  • Merck KGaA
  • Sartorius AG
  • Solaris Biotechnology Srl
  • Thermo Fisher Scientific Inc.

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Vendor offerings
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Bags and mixers - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Bags and mixers - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Bioreactors and fermenters - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Bioreactors and fermenters - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Filtration devices and sampling systems - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Filtration devices and sampling systems - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Bioprocess containers - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 27: Bioprocess containers - Year-over-year growth 2020-2024 (%)
  • Exhibit 28: Other products - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: Other products - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Market opportunity by product
  • Exhibit 31: Application - Market share 2019-2024 (%)
  • Exhibit 32: Comparison by application
  • Exhibit 33: mAb production - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 34: mAb production - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: Vaccine production - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: Vaccine production - Year-over-year growth 2020-2024 (%)
  • Exhibit 37: Plant cell cultivation - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: Plant cell cultivation - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: PSCTs - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 40: PSCTs - Year-over-year growth 2020-2024 (%)
  • Exhibit 41: Other applications - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 42: Other applications - Year-over-year growth 2020-2024 (%)
  • Exhibit 43: Market opportunity by application
  • Exhibit 44: Customer landscape
  • Exhibit 45: End-user - Market share 2019-2024 (%)
  • Exhibit 46: Comparison by end-user
  • Exhibit 47: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 48: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 49: CROs and CMOs - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 50: CROs and CMOs - Year-over-year growth 2020-2024 (%)
  • Exhibit 51: Biotechnology companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 52: Biotechnology companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 53: Academic and research institutions - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 54: Academic and research institutions - Year-over-year growth 2020-2024 (%)
  • Exhibit 55: Market opportunity by end-user
  • Exhibit 56: Market share by geography 2019-2024 (%)
  • Exhibit 57: Geographic comparison
  • Exhibit 58: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 59: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 60: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 61: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 62: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 63: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 64: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 65: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 66: Key leading countries
  • Exhibit 67: Market opportunity
  • Exhibit 68: Impact of drivers and challenges
  • Exhibit 69: Vendor landscape
  • Exhibit 70: Landscape disruption
  • Exhibit 71: Vendors covered
  • Exhibit 72: Vendor classification
  • Exhibit 73: Market positioning of vendors
  • Exhibit 74: 3M Co. - Vendor overview
  • Exhibit 75: 3M Co. - Business segments
  • Exhibit 76: 3M Co. - Organizational developments
  • Exhibit 77: 3M Co. - Geographic focus
  • Exhibit 78: 3M Co. - Segment focus
  • Exhibit 79: 3M Co. - Key offerings
  • Exhibit 80: Avantor Inc. - Vendor overview
  • Exhibit 81: Avantor Inc. - Product segments
  • Exhibit 82: Avantor Inc. - Organizational developments
  • Exhibit 83: Avantor Inc. - Key offerings
  • Exhibit 84: Compagnie de Saint-Gobain SA - Vendor overview
  • Exhibit 85: Compagnie de Saint-Gobain SA - Business segments
  • Exhibit 86: Compagnie de Saint-Gobain SA - Organizational developments
  • Exhibit 87: Compagnie de Saint-Gobain SA - Geographic focus
  • Exhibit 88: Compagnie de Saint-Gobain SA - Segment focus
  • Exhibit 89: Compagnie de Saint-Gobain SA - Key offerings
  • Exhibit 90: Danaher Corp. - Vendor overview
  • Exhibit 91: Danaher Corp. - Business segments
  • Exhibit 92: Danaher Corp. - Organizational developments
  • Exhibit 93: Danaher Corp. - Geographic focus
  • Exhibit 94: Danaher Corp. - Segment focus
  • Exhibit 95: Danaher Corp. - Key offerings
  • Exhibit 96: Eppendorf AG - Vendor overview
  • Exhibit 97: Eppendorf AG - Product segments
  • Exhibit 98: Eppendorf AG - Organizational developments
  • Exhibit 99: Eppendorf AG - Geographic focus
  • Exhibit 100: Eppendorf AG - Key offerings
  • Exhibit 101: General Electric Co. - Vendor overview
  • Exhibit 102: General Electric Co. - Business segments
  • Exhibit 103: General Electric Co. - Organizational developments
  • Exhibit 104: General Electric Co. - Geographic focus
  • Exhibit 105: General Electric Co. - Segment focus
  • Exhibit 106: General Electric Co. - Key offerings
  • Exhibit 107: Merck KGaA - Vendor overview
  • Exhibit 108: Merck KGaA - Business segments
  • Exhibit 109: Merck KGaA - Organizational developments
  • Exhibit 110: Merck KGaA - Geographic focus
  • Exhibit 111: Merck KGaA - Segment focus
  • Exhibit 112: Merck KGaA - Key offerings
  • Exhibit 113: Sartorius AG - Vendor overview
  • Exhibit 114: Sartorius AG - Business segments
  • Exhibit 115: Sartorius AG - Organizational developments
  • Exhibit 116: Sartorius AG - Geographic focus
  • Exhibit 117: Sartorius AG - Segment focus
  • Exhibit 118: Sartorius AG - Key offerings
  • Exhibit 119: Solaris Biotechnology Srl - Vendor overview
  • Exhibit 120: Solaris Biotechnology Srl - Product segments
  • Exhibit 121: Solaris Biotechnology Srl - Key offerings
  • Exhibit 122: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 123: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 124: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 125: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 126: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 128: Validation techniques employed for market sizing
  • Exhibit 129: Definition of market positioning of vendors
Back to Top